ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value

Folia Histochemica et Cytobiologica

Volumn 46, Issue 2, 2008, Pages 147-152

  Hus, Iwona ^a   Bojarska Junak, Agnieszka ^a   Dmoszyńska, Anna ^a   Wasik Szczepanek, Ewa ^a   Sieklucka, Małgorzata ^a   Trześniewska, Wioletta ^a   Glazer, Magdalena ^a   Roliński, Jacek ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

B cell chronic lymphocytic leukaemia; CD38; Prognostic factors; ZAP 70

Indexed keywords

CD19 ANTIGEN; CD38 ANTIGEN; PROTEIN KINASE ZAP 70; ZAP70 PROTEIN, HUMAN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; INTRACELLULAR SPACE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PHENOTYPE; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD38; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTRACELLULAR SPACE; KAPLAN-MEIERS ESTIMATE; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 48449095870     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-008-0022-7     Document Type: Article

References (23)

1. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, Buchbinder A, Budman D, Dittmar K, Kolitz J, Lichtman SM, Schulman P, Vinciguerra VP, Rai KR, Ferrarini M, Chiorazzi N. Ig V gene mutation status and CD 38 expression as a novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840-1847.
2. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94: 1848-1854.
3. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukaemia. N Engl J Med. 2003;348:1764-75.
4. Dürig J, Nückel H, Cremer M, Führer A, Halfmeyer K, Fandrey J, Möröy T, Klein-Hitpass L, Dührsen U. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukaemia. Leukemia. 2003;17:2426-34.
5. Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I, Lerner S, Kantarjian HM, Albitar M. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood. 2001;98:181-186.
6. Heintel D, Schwarzinger I, Chizzali-Bonfadin C, Thalhammer R, Schwarzmeier J, Fritzer-Szekeres M, Weltermann A, Simonitsch I, Lechner K, Jaeger U. Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia. Leuk Lymphoma. 2001;42:1315-1321.
7. Mainou-Fowler T, Dignum H, Taylor PR, Dickinson AM, Saunders PW, Proctor SJ, Summerfield GP. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia. Br J Haematol. 2002;118: 755-761.
8. Domingo-Domenech E, Domingo-Clarós A, Gonzalez-Barca E, Beneitez D, Alonso E, Romagosa V, De Sanjos S, Petit J, Granena A, Fernández de Sevilla A. CD38 expression in Bchronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. Haematologica. 2002; 87:1021-7.
9. Gentile M, Mauro FR, Calabrese E, De Propris MS, Giammartini E, Mancini F, Milani ML, Guarini A, Foa R. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience. Br J Haematol. 2005;130:549-57.
10. Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia. 2005;19:750-758.
11. Del Giudice I, Morilla A, Osuji N, Matutes E, Morilla R, Burford A, Maravelaki S, Owusu-Ankomah K, Swansbury J, A'Hern R, Brito-Babapulle V, Catovsky D. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Cancer. 2005;15:2124-32.
12. Hus I, Podhorecka M, Bojarska-Junak A, Roliński J, Schmitt M, Sieklucka M, Wasik-Szczepanek E, Dmoszyńska A. The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia. Ann Oncol. 2006;17: 683-90.
13. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996; 87:4990-4997.
14. Bojarska-Junak A, Giannopoulos K, Kowal M, Dmoszyýska A, Roliński J. Comparison of Methods for Determining Zeta-Chain Associated Protein - 70 (ZAP-70) Expression in Patients with B-Cell Chronic Lymphocytic Leukemia (BCLL). Cytometry B Clin Cytom. 2006; 70B:293-301.
15. Orchard JA, Ibbotson RE, Davis Z, Wiestner A, Rosenwald A, Thomas PW, Hamblin TJ, Staudt LM, Oscier DG. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet. 2004;363:105-11.
16. Del Principe MI, Del Poeta G, Buccisano F, Maurillo L, Venditti A, Zucchetto A, Marini R, Niscola P, Consalvo MA, Mazzone C, Ottaviani L, Panetta P, Bruno A, Bomben R, Suppo G, Degan M, Gattei V, de Fabritiis P, Cantonetti M, Lo Coco F, Del Principe D, Amadori S. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood. 2006;108:853-861.
17. Hamblin TJ, Orchard JA, Ibbotson RE, Davis Z, Thomas PW, Stevenson F. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 2002;99:1023-1029.
18. H gene mutational status, and loss or mutation of p53 gene are independent prognostic factors. Blood. 2002;100:1177-1184.
19. Matrai Z, Lin K, Dennis M, Sherrington P, Zuzel M, Pettitt AR, Cawley JC. CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia. Blood. 2001;97: 1902-1903.
20. Jelinek DF, Tschumper RC, Geyer SM, Bone ND, Dewald GW, Hanson CA, Stenson MJ, Witzig TE, Tefferi A, Kay NE. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol. 2001;115: 854-861.
21. Thunberg U, Johnson A, Roos G, Thörn I, Tobin G, Sällström J, Sundström C, Rosenquist R. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood. 2001;97:1892-1894.
22. Kröber A, Seiler T, Benner A, Bullinger L, Brückle E, Lichter P, Döhner H, Stilgenbauer S. VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 2002;100:1410-1416.
23. Bosch F, Crespo M, Villamor N, Muntanola A, Ferrer A, Domingo A: Clinical characteristics and outcome of a large series of patients with CLL according to ZAP-70 expression. Blood. 2004;104:8a.